The immune system is a crucial player in the development of cancer. Once it is in imbalance and immunosuppressive mechanisms supporting tumor growth take over control, dendritic cell immunotherapy might offer a solution to restore the balance. There are several methods to manufacture dendritic cells but none of them has yet proven to be superior to others. In this chapter, we discuss the methodology using electroporation of mRNA encoding Wilms’ tumor gene 1, survivin, and TriMix (mixture of caTLR4, CD40L, and CD70) to simultaneously load and mature dendritic cells.
CITATION STYLE
Coosemans, A., Tuyaerts, S., Morias, K., Corthals, J., Heirman, C., Thielemans, K., … Amant, F. (2016). mRNA electroporation of dendritic cells with WT1, survivin, and TriMix (a mixture of caTLR4, CD40L, and CD70). In Methods in Molecular Biology (Vol. 1428, pp. 277–283). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3625-0_18
Mendeley helps you to discover research relevant for your work.